Accounts Receivable and Notes Receivable (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2021

Dec. 31, 2020

TOI Parent Inc.

Accounts Receivable and Notes Receivable

Summary of accounts receivable

Accounts receivable as of September 30, 2021 and December 31, 2020 consist of the following:

	September 30,		December 31,
	2021		2020
Oral drug accounts receivable	$	2,668,582	$	2,307,872
Capitated accounts receivable		663,562		353,250
FFS accounts receivable		14,355,205		10,962,394
Clinical trials accounts receivable		1,947,626		1,718,846
Other trade receivables		2,621,630		1,803,548
Total	$	22,256,605	$	17,145,910

Accounts Receivable as of December 31, 2020 and 2019 consist of the following:

	December 31,		December 31,
	2020		2019
Oral drug accounts receivable	$	2,307,872	$	1,179,311
Capitated accounts receivable		353,250		96,000
FFS accounts receivable		10,962,394		10,904,721
Clinical trials accounts receivable		1,718,846		1,743,661
Other trade receivables		1,803,548		692,568
Total	$	17,145,910	$	14,616,261